A cancer treatment from Roche failed to improve survival in a major lung cancer study, a result that will stoke doubts about ...

Should patients with TNBC who did not receive immunotherapy before surgery get it after, if they have residual disease?

Clinical trials testing cancer immunotherapies have significantly under-represented Black patients. So while these treatments ...

Immunotherapy is a promising treatment that recruits the immune system to help fight cancer, but it has had limited success ...

When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...

Switzerland's Roche will acquire its U.S. collaboration partner Poseida Therapeutics in a cash deal worth up to $1.5 billion, ...

The Research Institute of the McGill University Health Centre is at the forefront of clinical trials in precision cancer ...

Brain metastases occur in as many as 50% of patients with melanoma and are associated with an "abysmal prognosis," said ...

Among 64 patients who received immune checkpoint inhibitors, 78% had downstaging of their liver tumor to within Milan ...

Combination of radiation, chemotherapy and immunotherapy can shrink tumors and allow surgery, with much better survival rate.

Min Li, Ph.D., a George Lynn Cross Professor of Medicine, Surgery and Cell Biology at the University of Oklahoma College of ...

There are several cancer therapies which are often confused, including chemotherapy, immunotherapy and targeted therapy.